Key result
Mechanical CAVV replacement is linked to similar mortality and survival as valvuloplasty in single-ventricle pediatric patients.
Why the study?
To evaluate the mid-term outcomes of mechanical valve replacement of the common atrioventricular valve in single-ventricle pediatric patients compared with valvuloplasty.
Does mechanical valve replacement improve overall survival and freedom from reintervention compared to valvuloplasty in single-ventricle pediatric patients undergoing CAVV surgery?
Cohort (n=91)
Does mechanical valve replacement improve overall survival and freedom from reintervention compared to valvuloplasty in single-ventricle pediatric patients undergoing CAVV surgery?
Mechanical valve replacement of the CAVV in single-ventricle pediatric patients provides satisfactory mid-term survival comparable to valvuloplasty, with potentially superior valve durability.
Answers are grounded in this paper and cite their sources.
Should not yet change practice for CAVV surgery in single-ventricle children; leaves open potential durability benefits of mechanical replacement.
Objectives To evaluate the mid-term outcomes of mechanical valve replacement of the common atrioventricular valve (CAVV) in single-ventricle pediatric patients and compare this with valvuloplasty. Methods We conducted a retrospective study of 91 single-ventricle pediatric patients who underwent CAVV surgery between 2014 and 2025. Patients were divided into two groups according to the initial surgery: valvuloplasty and mechanical valve replacement groups. Baseline and perioperative characteristics were compared between groups. Overall survival and freedom from reintervention were analyzed using Kaplan-Meier curves. Receiver operating characteristic (ROC) curve analysis and maximally selected rank statistics were used to determine the optimal cut-off values for cardiopulmonary bypass (CPB) and aortic cross-clamp (ACC) time in predicting in-hospital and late mortality. Results There were 78 cases in valvuloplasty and 13 cases in the mechanical valve replacement group. The replacement group had significantly longer CPB and ACC time ( p <0.001). In-hospital mortality was 2 out of 13 (15.4%) in the replacement group and 8 out of 78 (10.3%) in the valvuloplasty group ( p >0.050). The median follow-up was 39 months. Kaplan-Meier analysis showed no significant difference in overall survival ( p =0.280) and freedom from reintervention ( p =0.270). Reintervention for recurrent regurgitation was required in eight patients after ventriculoplasty, whereas no reintervention was observed following valve replacement. ROC analysis identified a CPB time of 173.5 min as the optimal cut-off for predicting in-hospital mortality,with an area under the curve (AUC) of 0.751. Patients with CPB duration exceeding 180 min had significantly poorer survival ( p =0.003). Conclusions Mechanical valve replacement of the CAVV in single-ventricle pediatric patients provides satisfactory mid-term survival comparable to valvuloplasty, but with superior valve durability. Prolonged CPB time is associated with poorer survival and should be minimized whenever possible.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Single-ventricle pediatric patients requiring common atrioventricular valve (CAVV) surgery (n=91). Mechanical valve replacement vs. Valvuloplasty was evaluated on In-hospital mortality (p=>0.050). Mechanical valve replacement of the CAVV in single-ventricle pediatric patients yielded similar in-hospital mortality (15.4% vs 10.3%, P>0.050) and overall survival compared to valvuloplasty.
Synapse has enriched 10 related papers. Consider them for comparative context: